Date: 2016-04-28
Type of information: Nomination
Compound:
Company: Shire (UK - USA)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On April 28, 2016, Shire announced that Olivier Bohuon, Non-Executive Director of the Company, has been appointed as a member of the Remuneration Committee with immediate effect.
Financial terms:
Latest news:
